Research from WashU Medicine reports encouraging long-term results for tofersen, an FDA-approved therapy for a rare genetic form of ALS caused by SOD1 mutations. Extended treatment slowed disease progression and improved survival, with about one-quarter of participants experiencing stabilization or gains in strength and mobility.
Research at Washington University in St. Louis has been recognized on the global stage, with WashU named a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min Kyung Shinn, PhD, at WashU’s McKelvey School of Engineering is uncovering new therapeutic targets for neurodegenerative disorders such as ALS.
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software & Computing Research Node and a professor of neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at Washington University in St. Louis.
The Q4 edition of the NEURO360 newsletter highlights key findings from nine community listening sessions conducted across the St. Louis region in partnership with the Integrated Health Network (IHN). Nearly 90 patients, caregivers, health providers, advocates, and rural partners shared insights that will shape NEURO360’s future initiatives. Highlights include the importance of trust and long-term […]
Over the past year, the NEURO360 team worked with its partner, the St. Louis Integrated Health Network (IHN) to host nine community listening sessions across the region—hearing directly from nearly 90 patients, caregivers, health providers, patient advocates, and rural partners. This work built on early outreach supported by Dr. Joyce Balls-Berry’s research lab at Washington […]
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon at WashU Medicine received a $5 million NIH grant to study how early‑life stress affects brain aging and Alzheimer’s.
NEURO360‑aligned research by Muriah D. Wheelock and Brian A. Gordon at WashU Medicine received a $5 million NIH grant to study how early‑life stress affects brain aging and Alzheimer’s.
Lan Yang has been named one of the world’s most highly cited researchers by the Institute for Scientific Information, ranking among the top 1% in her field over the past decade.
Jeff Milbrandt, MD, PhD, has been awarded the inaugural WashU Medicine Dean’s Medal for Innovation and Commercialization, recognizing his transformative discoveries in neurodegeneration and his leadership in translating breakthrough science into therapies.
